Bryan Harris, Executive Vice President and CTO at SAS
A recent global study by SAS and Coleman Parkes Research reveals that China leads in generative AI (GenAI) usage, with 83% of organizations adopting the technology, compared to 65% in the US.
However, the US excels in full implementation, at 24%, versus China’s 19%. Despite higher adoption in China, effective implementation and returns are better in the US.
“With any new technology, organizations must navigate a discovery phase, separating hype from reality, to understand the complexity of real-world implementations in the enterprise. We have reached this moment with generative AI,” says Bryan Harris, Executive Vice President and CTO at SAS.
“As we exit the hype cycle, it is now about purposefully implementing and delivering repeatable and trusted business results from GenAI.”
The study highlights that organizations face challenges like data privacy, security, and understanding of GenAI, underscoring the need for strategic integration as they navigate this transformative technology.
“While China may lead in GenAI adoption rates, higher adoption doesn’t necessarily equate to effective implementation or better returns,” says Stephen Saw, Managing Director at Coleman Parkes.
“In fact, the US nudges ahead in the race with 24% of organizations having fully implemented GenAI compared to 19% in China.”
Malaysia is reviewing its petroleum reserves to enhance energy security and address global supply uncertainties…
A new Washington Post-Ipsos poll shows Democrats leading Republicans ahead of the 2026 US midterms,…
A former bank analyst has been sentenced to jail after falsely presenting himself as a…
Budget 2027 will prioritize economic growth, rakyat welfare, and sustainability, addressing current challenges while ensuring…
WellCall Holdings may rise if RM1.19 resistance is breached, otherwise selling pressure could increase.
FEYTECH shows potential for a price increase if it breaks RM0.245 resistance, but risks decline…
This website uses cookies.